Sanofi, Regeneron Partnership Yields Promising New Eczema Drug

July 10, 2014 11:00 AM

35 0

Sanofi, Regeneron Partnership Yields Promising New Eczema Drug

A partnership between Sanofi and Regeneron has yielded a promising treatment for eczema and other skin diseases. The drug, Dupilumab, is now being advanced to late stage testing stages

Sanofi S.A (SNY) and Regeneron Pharmaceuticals Inc (REGN) have seen positive results from the second-phase testing of experimental treatment Dupiluma. The drug was being used to treat extreme atopic dermatitis, which is commonly known as eczema.

Read more

To category page

Loading...